Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?
Authors
Keywords
-
Journal
LEUKEMIA
Volume 32, Issue 7, Pages 1500-1514
Publisher
Springer Nature
Online
2018-02-22
DOI
10.1038/s41375-018-0061-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway
- (2017) Pan Zhao et al. LEUKEMIA RESEARCH
- Telomere length is positively associated with the expression of IL-6 and MIP-1α in bone marrow mesenchymal stem cells of multiple myeloma
- (2017) Shengli Li et al. Molecular Medicine Reports
- Mechanoresponsive stem cells to target cancer metastases through biophysical cues
- (2017) Linan Liu et al. Science Translational Medicine
- Pretreatment with Bisphosphonate Enhances Osteogenesis of Bone Marrow Mesenchymal Stem Cells
- (2017) Lei Hu et al. STEM CELLS AND DEVELOPMENT
- Zoledronic acid in vivo increases in vitro proliferation of rat mesenchymal stromal cells
- (2016) Terhi J Heino et al. Acta Orthopaedica
- Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity
- (2016) Kim De Veirman et al. CANCER LETTERS
- Multiple myeloma–derived MMP-13 mediates osteoclast fusogenesis and osteolytic disease
- (2016) Jing Fu et al. JOURNAL OF CLINICAL INVESTIGATION
- Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma
- (2016) G McNee et al. LEUKEMIA
- A Lysophosphatidic Acid Receptors 1 and 3 Axis Governs Cellular Senescence of Mesenchymal Stromal Cells and Promotes Growth and Vascularization of Multiple Myeloma
- (2016) Masahiko Kanehira et al. STEM CELLS
- Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)
- (2016) Cesarina Giallongo et al. Oncotarget
- CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway
- (2015) Dan Wu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region
- (2015) Rimma Berenstein et al. BMC CANCER
- Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myeloma
- (2015) R H Prabhala et al. LEUKEMIA
- Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223
- (2015) Rimma Berenstein et al. MOLECULAR CARCINOGENESIS
- Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription
- (2015) Wenzhuo Zhuang et al. STEM CELLS
- A Peculiar Molecular Profile of Umbilical Cord-Mesenchymal Stromal Cells Drives Their Inhibitory Effects on Multiple Myeloma Cell Growth and Tumor Progression
- (2015) Sabino Ciavarella et al. STEM CELLS AND DEVELOPMENT
- Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells
- (2014) Thibaud André et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells
- (2014) Julia Dotterweich et al. Cell Communication and Signaling
- SDF-1α stiffens myeloma bone marrow mesenchymal stromal cells through the activation of RhoA-ROCK-Myosin II
- (2014) Dong Soon Choi et al. INTERNATIONAL JOURNAL OF CANCER
- Induction of thymic stromal lymphopoietin in mesenchymal stem cells by interaction with myeloma cells
- (2014) Shinji Nakajima et al. LEUKEMIA & LYMPHOMA
- Up-regulation of connexin-43 expression in bone marrow mesenchymal stem cells plays a crucial role in adhesion and migration of multiple myeloma cells
- (2014) Xiaohui Zhang et al. LEUKEMIA & LYMPHOMA
- The Osteoblastogenesis Potential of Adipose Mesenchymal Stem Cells in Myeloma Patients Who Had Received Intensive Therapy
- (2014) Hsiu-Hsia Lin et al. PLoS One
- Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo
- (2013) Song Xu et al. ACTA PHARMACOLOGICA SINICA
- The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling
- (2013) Martin F. Kaiser et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells
- (2013) J. E. Noll et al. HAEMATOLOGICA
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
- (2013) Aldo M. Roccaro et al. JOURNAL OF CLINICAL INVESTIGATION
- Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells
- (2013) Thibaud André et al. PLoS One
- Upregulation of miR-135b Is Involved in the Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients
- (2013) Song Xu et al. PLoS One
- Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
- (2013) Ikiru Atsuta et al. Stem Cell Research & Therapy
- In vitro expanded bone marrow-derived murine (C57Bl/KaLwRij) mesenchymal stem cells can acquire CD34 expression and induce sarcoma formation in vivo
- (2012) Song Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells
- (2012) Jaehyup Kim et al. BRITISH JOURNAL OF HAEMATOLOGY
- In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells
- (2012) Sabino Ciavarella et al. BRITISH JOURNAL OF HAEMATOLOGY
- Bioactivity and Prognostic Significance of Growth Differentiation Factor GDF15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma
- (2012) J. Corre et al. CANCER RESEARCH
- Sclerostin: a possible target for the management of cancer-induced bone disease
- (2012) Maria Gkotzamanidou et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation
- (2012) MASAYOSHI YAMAGUCHI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth
- (2012) Xin Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway
- (2012) S Xu et al. LEUKEMIA
- Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells
- (2012) M Bolzoni et al. LEUKEMIA
- Human Platelet Lysate Gel Provides a Novel Three Dimensional-Matrix for Enhanced Culture Expansion of Mesenchymal Stromal Cells
- (2012) Gudrun Walenda et al. TISSUE ENGINEERING PART C-METHODS
- Development and Characterization of a Clinically Compliant Xeno-Free Culture Medium in Good Manufacturing Practice for Human Multipotent Mesenchymal Stem Cells
- (2012) Lucas G. Chase et al. Stem Cells Translational Medicine
- Sclerostin is overexpressed by plasma cells from multiple myeloma patients
- (2011) Giacomina Brunetti et al. Annals of the New York Academy of Sciences
- Impairment in Immunomodulatory Function of Mesenchymal Stem Cells from Multiple Myeloma Patients
- (2011) Bingzong Li et al. ARCHIVES OF MEDICAL RESEARCH
- Myeloma cells inhibit osteogenic differentiation of mesenchymal stem cells and kill osteoblasts via TRAIL-induced apoptosis
- (2011) Jinxiang Fu et al. Archives of Medical Science
- Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease
- (2011) S. D'Souza et al. BLOOD
- Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts
- (2011) Meghan E. McGee-Lawrence et al. BONE
- Brain-derived neurotrophic factor is a potential osteoclast stimulating factor in multiple myeloma
- (2011) Chun-Yan Sun et al. INTERNATIONAL JOURNAL OF CANCER
- Growth factor-defined culture medium for human mesenchymal stem cells
- (2011) Sumiyo Mimura et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function
- (2011) S Vallet et al. LEUKEMIA
- Stable Changes in Mesenchymal Stromal Cells from Multiple Myeloma Patients Revealed through Their Responses to Toll-Like Receptor Ligands and Epidermal Growth Factor
- (2011) Meirav Pevsner-Fischer et al. Stem Cell Reviews and Reports
- Bone Marrow-Derived Mesenchymal Stromal Cells are Attracted by Multiple Myeloma Cell-Produced Chemokine CCL25 and Favor Myeloma Cell Growth in Vitro and In Vivo
- (2011) Song Xu et al. STEM CELLS
- The formation of osteoclasts in multiple myeloma bone disease patients involves the secretion of soluble decoy receptor 3
- (2010) Giacomina Brunetti et al. Annals of the New York Academy of Sciences
- A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma
- (2010) K. Noonan et al. BLOOD
- Angiogenic Activity of Mesenchymal Stem Cells in Multiple Myeloma
- (2010) Xiaofang Wang et al. CANCER INVESTIGATION
- Bone marrow stromal cell interaction reduces Syndecan-1 expression and induces kinomic changes in myeloma cells
- (2010) Gwenny M. Fuhler et al. EXPERIMENTAL CELL RESEARCH
- Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo
- (2010) Andrew D Chantry et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Survivin is upregulated in myeloma cell lines cocultured with mesenchymal stem cells
- (2010) Xiaofang Wang et al. LEUKEMIA RESEARCH
- The Histone Deacetylase Inhibitor, Vorinostat, Reduces Tumor Growth at the Metastatic Bone Site and Associated Osteolysis, but Promotes Normal Bone Loss
- (2010) J. Pratap et al. MOLECULAR CANCER THERAPEUTICS
- TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
- (2010) Kyoko Takeuchi et al. PLoS One
- Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease
- (2010) S. Vallet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone
- (2010) Xin Li et al. STEM CELLS
- Efficacy Assessment of Interferon-Alpha–Engineered Mesenchymal Stromal Cells in a Mouse Plasmacytoma Model
- (2010) Silvia Sartoris et al. STEM CELLS AND DEVELOPMENT
- An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma
- (2009) Ravi Vij et al. AMERICAN JOURNAL OF HEMATOLOGY
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
- (2009) M. Fulciniti et al. BLOOD
- Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells
- (2009) S. Lee et al. CELL PROLIFERATION
- A High-Affinity Fully Human Anti-IL-6 mAb, 1339, for the Treatment of Multiple Myeloma
- (2009) M. Fulciniti et al. CLINICAL CANCER RESEARCH
- Vorinostat enhances the antimyeloma effects of melphalan and bortezomib
- (2009) Richard A. Campbell et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease
- (2009) Katia Todoerti et al. EXPERIMENTAL HEMATOLOGY
- Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors
- (2009) M Garayoa et al. LEUKEMIA
- Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells
- (2008) Barbara Zdzisińska et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Bone marrow microenvironment and the identification of new targets for myeloma therapy
- (2008) K Podar et al. LEUKEMIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now